SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SWTX SpringWorks Therapeutics, Inc.

已收盘 08-16 16:00:00 EDT

36.35

+0.14

+0.39%

盘后36.35

+0.000.00%

16:52 EDT

最高36.80	最低35.61	成交量54.66万
今开36.10	昨收36.21	日振幅3.29%
总市值26.98亿	流通市值26.43亿	总股本7,424万
成交额1,980万	换手率0.75%	流通股本7,272万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SWTX","market":"US","secType":"STK","nameCN":"SpringWorks Therapeutics, Inc.","latestPrice":36.35,"timestamp":1723838400000,"preClose":36.21,"halted":0,"volume":546627,"hourTrading":{"tag":"盘后","latestPrice":36.35,"preClose":36.35,"latestTime":"16:52 EDT","volume":22298,"amount":810533.95,"timestamp":1723841538855},"delay":0,"floatShares":72718693,"shares":74235882,"eps":-4.368549,"marketStatus":"已收盘","marketStatusCode":5,"change":0.14,"latestTime":"08-16 16:00:00 EDT","open":36.1,"high":36.8,"low":35.61,"amount":19799611.616609998,"amplitude":0.032864,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.368549,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1568347200000,"adjPreClose":36.21,"postHourTrading":{"tag":"盘后","latestPrice":36.35,"preClose":36.35,"latestTime":"16:52 EDT","volume":22298,"amount":810533.95,"timestamp":1723841538855},"volumeRatio":0.802185,"impliedVol":0.5322,"impliedVolPercentile":0.0476},"requestUrl":"/m/hq/s/SWTX/wiki","defaultTab":"wiki","newsList":[{"id":"2459477511","title":"Springworks Therapeutics, Inc.2024财年第二财季实现净利润-39.92百万美元，同比增加48.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459477511","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459477511?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:04","pubTimestamp":1723737864,"startTime":"0","endTime":"0","summary":"8月16日，Springworks Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-39.92百万美元，同比增加48.77%；其中营业收入为59.73百万美元，每股基本收益为-0.54美元。从资产负债表来看，Springworks Therapeutics, Inc.总负债60.60百万美元，其中短期债务958000.00美元，资产负债比为0.11，流动比率为0.08。机构评级：截至2024年8月16日，当前有8家机构对Springworks Therapeutics, Inc.目标价做出预测，其中目标均价为67.38美元，其中最低目标价为58.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160004369f2e468f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160004369f2e468f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","LENZ"],"gpt_icon":0},{"id":"2457875841","title":"BUZZ--美国股票走势-雅培实验室、美敦力、Axon","url":"https://stock-news.laohu8.com/highlight/detail?id=2457875841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457875841?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:47","pubTimestamp":1723056454,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月7日 - 华尔街主要股指周三上扬，受助于大型股的上涨，以及日本最高决策者在上周意外加息后转为鸽派，这在一定程度上引发了全球市场的剧烈波动。美东时间14:35 ，道琼斯工业平均指数  下跌0.52%，报38,793.6 点。标普500指数  下跌0.53%，报5,212.5点；纳斯达克综合指数  下跌0.77%，报16,240.061点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVX","DJX","GTHX","BKR","NYT","SMCI","INSP","ROK","LYFT","PODD","DXD","DIS","UDOW",".DJI","DXCM","CYRX","DDM","XOM","TNDM","NQmain","PETQ","VCYT","SWTX","APA","AMGN","BUZZ","CRL","TSVT","AXON","PGNY","EMR","CART","QID",".IXIC","IEP","OSCR","REAL","ILMN","NEXT","TECH","PSQ","MDT",".SPX","SDOW","ABT"],"gpt_icon":1},{"id":"1135033429","title":"异动解读 | SpringWorks Therapeutics第二季度营收超预期 股价大涨18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135033429","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135033429?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:36","pubTimestamp":1723037801,"startTime":"0","endTime":"0","summary":"SpringWorks Therapeutics, Inc.今日盘中大涨18.27%,引发市场广泛关注。根据公司最新财报,SpringWorks Therapeutics在第二季度实现营业收入5970万美元,超过华尔街预期的3430万美元。该公司第二季度每股亏损54美分,较去年同期每股亏损1.25美元有所收窄。营收超预期是导致SpringWorks Therapeutics股价大涨的主要原因。分析人士表示,市场对该公司的业绩表现给予了积极评价,认为其未来发展前景向好。SpringWorks Therapeutics是一家专注于研发针对严重罕见疾病和高度致命性癌症的新型治疗方法的生物制药公司,其产品管线前景广阔。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX"],"gpt_icon":0},{"id":"2457844804","title":"Springworks Therapeutics, Inc.股价拉升20.41% 市值涨6.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844804","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844804?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:30","pubTimestamp":1723037426,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时30分，Springworks Therapeutics, Inc.股票出现异动，股价急速拉升20.41%。截至发稿，该股报40.00美元/股，成交量1.2012万股，换手率0.02%，振幅0.00%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213026af96686e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213026af96686e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SWTX","BK4139"],"gpt_icon":0},{"id":"1135743142","title":"异动解读 | SpringWorks Therapeutics第二季度营收超预期 股价盘前大涨11.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135743142","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135743142?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:14","pubTimestamp":1723036459,"startTime":"0","endTime":"0","summary":"SpringWorks Therapeutics, Inc.今日盘前大涨11.35%,引发市场广泛关注。\n\n根据相关新闻报道,SpringWorks Therapeutics在第二季度实现营业收入5970万美元,超过华尔街预期的3430万美元。该公司第二季度每股亏损54美分,较去年同期每股亏损1.25美元有所收窄。\n\n营收超预期是导致SpringWorks Therapeutics股价大涨的主要原因。市场对该公司的业绩表现给予了积极评价,认为其未来发展前景向好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX"],"gpt_icon":0},{"id":"2457810966","title":"BUZZ--美国股票走势-华特迪士尼、SpringWorks、Shopify","url":"https://stock-news.laohu8.com/highlight/detail?id=2457810966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457810966?lang=zh_cn&edition=full","pubTime":"2024-08-07 20:10","pubTimestamp":1723032604,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月7日 - 美国股指期货周三跳涨，原因是风险偏好在本周早些时候大幅下挫后有所恢复，一位有影响力的日本央行决策者对加息的谨慎评论也提振了市场情绪。美东时间7:59，道指电子盘  上涨0.86%，报39,478 点。标普500指数小型股  上涨1.02%，报5319.75点；纳斯达克100指数小型股  上涨1.14%，报18385.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4561","BUZZ","SG9999015952.SGD","UPST","GTHX","BK4154","LU2023250843.SGD","BK4108","BK4532","LU0122379950.USD","BK4554","IE0002141913.USD","IE00B19Z9Z06.USD","GB00BDT5M118.USD","BK4230","LU0029864427.USD","CVS","LU0868494617.USD","AMGN","SHOP","LU2286300806.USD","BK4560","LU0128525929.USD","SG9999015986.USD","FTNT","BK4551","HLT","NEXT","BK4144","BK4524","PGNY","LU1571399168.USD","TRIP","LU0708994859.HKD","SG9999015945.SGD","LU0011850046.USD","LYFT","LU0208291251.USD","EBS","BK4585","SWTX","LU0061475181.USD","IE00B4R5TH58.HKD","DIS","LU0058720904.USD","LU0823411888.USD","LU1061106388.HKD","LU0320765489.SGD","BK4142","LU2106854487.HKD"],"gpt_icon":1},{"id":"2457078816","title":"BUZZ-SpringWorks 因第二季度收入超预期而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2457078816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457078816?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:58","pubTimestamp":1723028310,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月7日 - ** SpringWorks Therapeutics   股价盘前上涨5.3%至34.97美元** 制药商第二季度实现营业收入5970万美元，超过华尔街预期的3430万美元 - LSEG** 该公司第二季度每股亏损 54 美分，比去年同期每股亏损 1.25 美元有所收窄。** 截至上日收盘，股价累计下跌 9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","SWTX","BK4139"],"gpt_icon":0},{"id":"2457977218","title":"SpringWorks Therapeutics Inc   预计每股亏损1.11美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457977218","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457977218?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:24","pubTimestamp":1722871451,"startTime":"0","endTime":"0","summary":"   * SpringWorks Therapeutics Inc    将于8月7日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于康涅狄格州斯坦福德的公司预计将实现营收3434.3万美元。* LSEG 分析师对 SpringWorks Therapeutics Inc 的平均预期是每股亏损 1.11 美元。* 华尔街对 SpringWorks Therapeutics Inc 的 12 个月目标价中位数为 63.13 美元，高于其上次收盘价 33.43 美元。8月5日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX","LENZ"],"gpt_icon":0},{"id":"2456281060","title":"Springworks Therapeutics, Inc.盘中异动 大幅下挫10.55%报31.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456281060","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456281060?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:30","pubTimestamp":1722605445,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时30分，Springworks Therapeutics, Inc.股票出现波动，股价快速跳水10.55%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213046af95a552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213046af95a552&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SWTX"],"gpt_icon":0},{"id":"2453085797","title":"Springworks Therapeutics, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453085797","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453085797?lang=zh_cn&edition=full","pubTime":"2024-07-23 00:01","pubTimestamp":1721664064,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日00时01分，Springworks Therapeutics, Inc.股票出现异动，股价大幅下挫5.06%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230001049681eee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230001049681eee4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SWTX","BK4139"],"gpt_icon":0},{"id":"2452433146","title":"Springworks Therapeutics, Inc.盘中异动 早盘大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452433146","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452433146?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:42","pubTimestamp":1721313769,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时42分，Springworks Therapeutics, Inc.股票出现异动，股价急速下跌5.05%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182242499681e195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182242499681e195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2441137590","title":"SpringWorks Therapeutics Inc.（SWTX.US）宣布，终止与葛兰素史克的协议，葛兰素史克将继续试验Nirogacestat Combo。","url":"https://stock-news.laohu8.com/highlight/detail?id=2441137590","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441137590?lang=zh_cn&edition=full","pubTime":"2024-06-08 04:21","pubTimestamp":1717791675,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["LENZ","BK4139","BK4532","LU0289739699.SGD","LU0058720904.USD","GSK.UK","LU0971552673.USD","IE00BWDBJ516.SGD","SWTX","LU1481600234.SGD","IE00BQJZX424.USD","BK5011","IE0034235071.USD","GSK","LU1481599808.USD","BK4007","LU1400636657.SGD","LU1829250122.USD","LU1400636491.USD","LU1487256676.USD","LU1046248800.SGD","LU0321505868.SGD","LU0211331839.USD","LU0321505439.SGD","BK4585","LU1064927863.SGD","BK4588"],"gpt_icon":0},{"id":"2439660899","title":"HC Wainwright &amp; Co.：重申SpringWorks Therapeutics(SWTX.US)评级，由买入调整至买入评级, 目标价由74.","url":"https://stock-news.laohu8.com/highlight/detail?id=2439660899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439660899?lang=zh_cn&edition=full","pubTime":"2024-05-31 18:15","pubTimestamp":1717150559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SWTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2434896903","title":"Springworks Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434896903","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434896903?lang=zh_cn&edition=full","pubTime":"2024-05-11 03:52","pubTimestamp":1715370771,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日03时52分，Springworks Therapeutics, Inc.股票出现异动，股价快速下跌5.01%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511035252861ec807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240511035252861ec807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SWTX","BK4139"],"gpt_icon":0},{"id":"2434869688","title":"Springworks Therapeutics, Inc.2024财年第一财季实现净利润-87.39百万美元，同比减少19.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434869688","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434869688?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:17","pubTimestamp":1715357835,"startTime":"0","endTime":"0","summary":"3月31日，Springworks Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-87.39百万美元，同比减少19.03%；其中营业收入为21.01百万美元，每股基本收益为-1.18美元。从资产负债表来看，Springworks Therapeutics, Inc.总负债89.39百万美元，其中短期债务981000.00美元，资产负债比为0.08，流动比率为0.07。机构评级：截至2024年3月31日，当前有9家机构对Springworks Therapeutics, Inc.目标价做出预测，其中目标均价为67.92美元，其中最低目标价为58.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100171987516d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100171987516d06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","LENZ"],"gpt_icon":0},{"id":"2426491231","title":"Springworks Therapeutics, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426491231","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426491231?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:32","pubTimestamp":1712755934,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时32分，Springworks Therapeutics, Inc.股票出现异动，股价快速下挫5.08%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213215861e4a49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213215861e4a49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SWTX"],"gpt_icon":0},{"id":"2417429542","title":"HC Wainwright &amp; Co.：维持SpringWorks Therapeutics(SWTX.US)评级，由买入调整至买入评级, 目标价由73.","url":"https://stock-news.laohu8.com/highlight/detail?id=2417429542","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417429542?lang=zh_cn&edition=full","pubTime":"2024-03-06 21:27","pubTimestamp":1709731622,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SWTX","BK4139"],"gpt_icon":0},{"id":"2417200459","title":"美国研究综述-树皮、Fleetcor Technologies、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2417200459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417200459?lang=zh_cn&edition=full","pubTime":"2024-03-05 14:57","pubTimestamp":1709621845,"startTime":"0","endTime":"0","summary":"    路透社3月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Bark、Fleetcor Technologies 和特斯拉。要闻             * Bark Inc   ：杰富瑞将其评级从 \"持有 \"上调至 \"买入\"；将交易价从1.54美元上调至1.9美元。* Fleetcor Technologies Inc   ：贝尔德将其评级上调至 \"跑赢大盘\"。* 特斯拉  ：加拿大皇家银行将目标价从297美元上调至298美元 以下是路透社周二报道的美国公司研究报告摘要。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSP","PLNT","CQP","LU1670628061.USD","PNTG","BK4099","LU1496350171.SGD","LU0310799852.SGD","RNA","BK4097","CCCC","FLT","NTRA","BLD","LU0097036916.USD","LU1839511570.USD","TSLL","APG","CCOI","HGV","PDCO","SFIX","PCAR","LU0011850046.USD","SWTX","AMRC","PAY","HSIC","MGX","NUVL","XPOF","AKRO","HIMS","TSLA","BLUE","AMPH","COST","BARK","SQSP","IE0004445015.USD","LU1720051017.SGD","LU1861558580.USD","GTLB","APLS","BK4149","AKYA","IBP","PRVA","GWW","UNH"],"gpt_icon":0},{"id":"2416964633","title":"Springworks Therapeutics, Inc.2023财年实现净利润-3.25亿美元，同比减少17.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416964633","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416964633?lang=zh_cn&edition=full","pubTime":"2024-03-03 00:18","pubTimestamp":1709396331,"startTime":"0","endTime":"0","summary":"12月31日，Springworks Therapeutics, Inc.公布财报，公告显示公司2023财年净利润为-3.25亿美元，同比减少17.33%；其中营业收入为5.45百万美元，每股基本收益为-5.15美元。从资产负债表来看，Springworks Therapeutics, Inc.总负债99.57百万美元，其中短期债务1.06百万美元，资产负债比为0.08，流动比率为0.07。机构评级：截至2023年12月31日，当前有8家机构对Springworks Therapeutics, Inc.目标价做出预测，其中目标均价为67.53美元，其中最低目标价为58.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300185687dce6f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300185687dce6f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX"],"gpt_icon":0},{"id":"2416064186","title":"Springworks Therapeutics, Inc.盘中异动 大幅拉升5.14%报51.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416064186","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416064186?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:37","pubTimestamp":1709303871,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时37分，Springworks Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc是一家处于临床阶段的生物制药公司，采用精准医学的方法，为患有严重罕见疾病和癌症的患者购买、开发并商业化可以改变生命的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012237517a48953f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012237517a48953f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.springworkstx.com","stockEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.136},{"period":"3month","weight":-0.1925},{"period":"6month","weight":-0.3087},{"period":"1year","weight":0.2719},{"period":"ytd","weight":-0.0079}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"SpringWorks Therapeutics, Inc.于2017年8月在特拉华州成立。该公司是一家临床阶段的生物制药公司，它使用精密医学来为患有严重疾病和癌症的服务不足的患者人群获取，开发和商品化改变生命的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.056257},{"month":2,"riseRate":1,"avgChangeRate":0.03933},{"month":3,"riseRate":0,"avgChangeRate":-0.099358},{"month":4,"riseRate":0.2,"avgChangeRate":-0.057063},{"month":5,"riseRate":0.6,"avgChangeRate":-0.021348},{"month":6,"riseRate":0.6,"avgChangeRate":0.056003},{"month":7,"riseRate":0.8,"avgChangeRate":0.083729},{"month":8,"riseRate":0.4,"avgChangeRate":-0.049234},{"month":9,"riseRate":0.5,"avgChangeRate":-0.058511},{"month":10,"riseRate":0.4,"avgChangeRate":-0.00268},{"month":11,"riseRate":1,"avgChangeRate":0.145659},{"month":12,"riseRate":0.8,"avgChangeRate":0.186995}],"exchange":"NASDAQ","name":"SpringWorks Therapeutics, Inc.","nameEN":"SpringWorks Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SpringWorks Therapeutics, Inc.(SWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SpringWorks Therapeutics, Inc.,SWTX,SpringWorks Therapeutics, Inc.股票,SpringWorks Therapeutics, Inc.股票老虎,SpringWorks Therapeutics, Inc.股票老虎国际,SpringWorks Therapeutics, Inc.行情,SpringWorks Therapeutics, Inc.股票行情,SpringWorks Therapeutics, Inc.股价,SpringWorks Therapeutics, Inc.股市,SpringWorks Therapeutics, Inc.股票价格,SpringWorks Therapeutics, Inc.股票交易,SpringWorks Therapeutics, Inc.股票购买,SpringWorks Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SpringWorks Therapeutics, Inc.(SWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}